Roche CEO Slams Europe For Failing To Reward Innovation
“The US and Asia really play to win, and I feel Europe is more and more playing not to lose,” Thomas Schinecker, CEO of the Swiss drugmaker, said in an interview on Bloomberg Television. Roche will“only invest in countries in the future that are also going to reward innovation.”
The comments are some of the 51-year-old executive's strongest to date, coming after Roche paused German investments to protest the government's cost-cutting healthcare reform. Germany and others are“not really investing in growth,” he said Thursday, echoing recent criticism by others in the industry.
More More Drug pricing Pharma pushes for higher European drug prices, Trump or no TrumpThis content was published on Oct 21, 2026 Pharmaceutical firms are still pressing Europe, including Switzerland, to raise drug prices despite limits to Trump's Most-Favoured Nation plan.
Read more: Pharma pushes for higher European drug prices, Trump or no
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment